‘Why Getting Fat, Doc?’ Weight Gain and Psychotropic Medications
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objectives: Weight gain associated with the use of psychotropic medications is a common clinical problem that is of particular importance because of its effects on the general health of psychiatric patients and their compliance with treatment. This paper aims to explore this issue and discuss the mechanisms of weight gain and methods of prevention. Method: A literature review ( Index Medicus/Medline) was carried out as well as a review of other relevant papers and data known to the authors. Results: Significant weight gain may result in considerable morbidity. The majority of psychotropic medications are associated with weight gain, however, the mechanisms of weight gain are often complex and poorly understood. Conclusion: Clinically, weight gain can be anticipated and often managed with some success in the majority of psychiatric patients with simple but relatively effective measures. It is important for clinicians to be aware of this common clinical problem and educate patients from the outset, monitoring them regularly and intervening when necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382 · cited 1×
“Weight gain is also associated with the other atypical antipsychotics such as risperidone, sertindole, ziprasidone and quetiapine, although it is not as marked as that with clozapine and olanzapine [63].”
BackgroundWeight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency
Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., Hughes, I. A., McCamish, M. A., & O'Rahilly, S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411204 · Cited by 1,998
Reduced Rate of Energy Expenditure as a Risk Factor for Body-Weight Gain
Ravussin, E., Lillioja, S., Knowler, W. C., Christin, L., Freymond, D., Abbott, W. G. H., Boyce, V., Howard, B. V., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802253180802 · Cited by 1,215 · cited 3×
“Though changes in hormones are often blamed for weight gain, in actual fact such hormonal changes are minor causes of major weight gain (> 10 kg) [14,15].”
BackgroundDavidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 1×
“Orlistat, a lipase inhibitor, blocks the gastrointestinal absorption of fat and is effective in combination with controlled dieting [71].”
BackgroundWeight, Weight Change, and Coronary Heart Disease in Women: Risk Within the 'Normal' Weight Range
Willett, W. C. (1995) · JAMA · doi:10.1001/jama.1995.03520300035033 · Cited by 924
A Prospective Study of Body Mass Index, Weight Change, and Risk of Stroke in Women
Rexrode, K. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540430051032 · Cited by 617 · cited 1×
“In the general population, being obese or overweight confers a significant increased risk of developing many medical diseases [4] for instance, type II non-insulin dependent diabetes mellitus (NIDDM) [5], ischaemic heart disease [6], hypertension [7], stroke [8], gall bladder disease [9] and some cancers [10,11].”
Background
Cited by
Onyike, C. U. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg275 · Cited by 827
Psychiatric Aspects of Child and Adolescent Obesity: A Review of the Past 10 Years
ZAMETKIN, A. J., ZOON, C. K., KLEIN, H. W., & MUNSON, S. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200402000-00008 · Cited by 336
Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
“The mood stabiliser’s use is optimized by monitoring plasma levels periodically [129].”
Himmerich, H., Koethe, D., Schuld, A., Yassouridis, A., & Pollm�cher, T. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2038-9 · Cited by 60
“Weight gain occurs during treatment with both substances (Zimmermann et al. 2003) and increases the patients’ risks of diabetes and cardiovascular or other obesity-related diseases ( Malhi et al. 2001 ).”
BackgroundLee, S. H., Mastronardi, C. A., Li, R. W., Paz-Filho, G., Dutcher, E. G., Lewis, M. D., Vincent, A. D., Smith, P. N., Bornstein, S. R., Licinio, J., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-018-0351-z · Cited by 12
Metadata
- Authors
- Malhi, G. S., Mitchell, P. B., & Caterson, I.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2001-06
- Volume
- 35
- Issue
- 3
- Pages
- 315-321
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2110217495
- Cited by
- 33
- References
- 7
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ‘Why Getting Fat, Doc?’ Weight Gain and Psychotropic Medications. https://app.cochat.ai/papers/10.1046/j.1440-1614.2001.00891.x
- The paper
- Malhi, G. S., Mitchell, P. B., & Caterson, I. (2001). ‘Why Getting Fat, Doc?’ Weight Gain and Psychotropic Medications. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1046/j.1440-1614.2001.00891.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.